Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 37Prostatic Neoplasms 19Multiple Myeloma 17Neoplasm Metastasis 14Osteoporosis 8Neuroblastoma 6Pain 5Osteosarcoma 5Neoplasms, Plasma Cell 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Bone Diseases, Metabolic 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteonecrosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Giant Cell Tumor of Bone 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Adenocarcinoma 2

Interventions

Risedronic Acid 4Calcium 4Zoledronic Acid 3Vitamin D 3Radiography, Panoramic 1Nutrition Assessment 1Ibandronic Acid 1Health Promotion 1Geritol 1Exercise Movement Techniques 1Exercise 1Cholecalciferol 1Calcium Carbonate 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Bone Diseases, Metabolic × Zoledronic Acid × Clear all
NCT01623908 2021-06-22

BLAZE

First Affiliated Hospital, Sun Yat-Sen University

Phase NA Terminated
200 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms

NCT00181584 2013-07-11

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Massachusetts General Hospital

Phase 2 Completed
60 enrolled
Genitourinary

Bone Diseases, Metabolic, Prostatic Neoplasms

NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡